CSIMarket
 

Hyperfine Inc   (NASDAQ: HYPR)

Hyperfine Inc 's

Competitiveness




 

HYPR Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Hyperfine Inc reported Revenue increase in the 1 quarter 2026 by 58.2 % year on year.
The sales growth was above Hyperfine Inc 's competitors' average revenue growth of 20.66 %, achieved in the same quarter.

List of HYPR Competitors





Revenue Growth Comparisons




Net Income Comparison


Hyperfine Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 21.94 %

<<  HYPR Stock Performance Comparisons


Hyperfine Inc 's Comment on Competition and Industry Peers


The company develops portable brain MRI systems, focusing on image quality through its Swoop® system powered by Optive AI™ software. Its first-generation portable brain MRI system was launched in 2020, with ongoing innovations to enhance AI-powered MRI imaging for broader adoption. In mid-2025, the company introduced its next-generation Swoop® scanner and Optive AI™ software, improving image resolution and uniformity in portable MRI. Competitors mentioned in company filings include the Bill & Melinda Gates Foundation and GV (formerly Google Ventures).



  

Overall company Market Share Q1 2026

Due to outstanding performance in Overall company, revenue grew by 58.2 % Hyperfine Inc improved its market share, to approximately 0.01 %.




<<  More on HYPR Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Hyperfine Inc




Accuray Incorporated
Share Performance



-82.91%
One Year



Accuray Incorporated
Profile

Accuray Incorporated is a medical technology company that focuses on the development and sale of radiation therapy systems. Their business model revolves around providing advanced and precise treatment options to cancer patients by combining robotics and imaging technologies. By delivering innovative solutions, Accuray aims to improve patient outcomes and establish partnerships with healthcare providers worldwide.

More about Accuray Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 31.223 mill. $ 400.833 mill. $ -49.194 mill.


Edap Tms Sa
Share Performance



+30.43%
This Quarter



Edap Tms Sa
Profile

Edap Tms Sa's business model revolves around providing minimally invasive medical devices and solutions for the treatment of urological diseases, specifically focusing on advanced ultrasound technologies for the diagnosis and treatment of prostate cancer and kidney stones.

More about Edap Tms Sa's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 191.393 mill. $ 111.051 mill. $ -59.221 mill.


Fonar Corporation
Share Performance



+31.47%
One Year



Fonar Corporation
Profile

Fonar Corporation operates as a medical technology company that specializes in the development, production, and marketing of magnetic resonance imaging (MRI) scanners. Their business model revolves around selling and servicing their proprietary MRI machines to healthcare facilities worldwide. They generate revenue through the sales of these scanners, as well as by providing additional services such as maintenance and support to their customers.

More about Fonar Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 131.053 mill. $ 105.338 mill. $ 8.529 mill.


General Electric Company
Share Performance



+3.22%
This Year



General Electric Company
Profile

General Electric Companys business model centers on industrial operations, creating and delivering advanced technologies, products, and services across sectors such as power generation, aviation, healthcare, and renewable energy. The company emphasizes innovation and sustainability, aiming to enhance performance and efficiency for customers while tackling pressing societal and environmental issues.

More about General Electric Company's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 346,651.230 mill. $ 50,638.000 mill. $ 8,982.000 mill.


Icad Inc
Share Performance



+24.04%
This Quarter



Icad Inc
Profile

Icad Inc operates on a business model that focuses on the development and commercialization of innovative cancer detection and therapy solutions. They primarily generate revenue through the sale of their advanced medical devices and software solutions to hospitals, clinics, and research institutions worldwide. Their business strategy revolves around continuous innovation, strategic partnerships, and a commitment to providing effective tools for early detection and treatment of cancer.

More about Icad Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 103.368 mill. $ 18.555 mill. $ -5.227 mill.

5 more competitors available

Sign in to see all competitors

Sources: Hyperfine Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Hyperfine Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.